Written by Elham Ajdadi, Maryam Esteghamati, Kambiz Ghasemi, Samira Zakeri Shahvari
Parent Category: Year 2014, Volume 6
Category: Year 2014, Volume 6, Issue 3, July-September 2014
Background: Idiopathic hypercalciuria is an important cause of symptoms related to the urinary system. The urinary excretion of high sodium and low potassium is a risk factor for hypercalciuria and urolithiasis. The aim of this study was to compare the urinary excretion of sodium and potassium by children older than two with idiopathic hypercalciuria and healthy control children in Bandar-Abbas, Iran.
Methods: This case control study was conducted during 2012 and 2013 in Bandar-Abbas, a city in southern Iran. The urinary excretion of sodium and potassium by 50 children with idiopathic hypercalciuria who were older than two was compared with that of 62 healthy children. IBM SPSS Statistics 21 software was used to analyze the data, and P < 0.05 was considered to be significant.
Results: Fifty children with idiopathic hypercalciuria (21 males and 29 females) were compared with 62 healthy children (19 males and 43 females). The results of the study indicated that there were no significant differences in the mean sodium and potassium levels in the urine of the two groups of children (P = 0.401 and P = 0.479, respectively.)
Conclusion: The study showed no significant differences in the excretion of sodium and potassium in the urine of children with idiopathic hypercalciuria and that of healthy children in Bandar-Abbas. This finding was inconsistent with the results of similar studies conducted earlier. Therefore, more studies are needed on populations in different areas with various climates and difference races.
Key words: idiopathic hypercalciuria, urine, sodium, potassium
kabelky, ruksaky知らないとオヤジ認定される36の若者言葉【随時更新】 , メンズファッションメディア
The most recent editorial (June 2021)
Ethics of Publishing Case Reports: Do We Need Ethics Approval and Patient Consent?
An editorial by Dr. Mehrdad Jalalian
The worldwide spread of COVID-19 as an emerging, rapidly evolving situation, and the dramatic need of urgent medicine or vaccine, has rapidly brought new hypotheses for pathophysiology and potential medicinal agents to the fore. It is crucial that the research community provide a way to publish this research in a timely manner.
To contribute to this important public health discussion, the Electronic Physician Journal is excited to announce a fast-track procedure to help researchers publish their articles on COVID-19 related subjects that fall under the broad definition of public health, internal medicine, and pharmacology. We are especially welcome to all hypotheses about the pathological basis of the COVID-19 infection and the possible characteristics of potential medicine and vaccine. Submit your manuscript here
Our previous editorial (June 2020)
Lessons from COVID-19 pandemic and the Morocco’s success story.
An editorial by Dr. Benksim Abdelhafid (Morocco)
The 6th World Conference on Research Integrity (WCRI) is to be held on June 2-5, 2019 in Hong Kong.
The WCRI is the largest and most significant international conference on research integrity. Since the first conference in Lisbon in 2007, it has given researchers, teachers, funding agencies, government officials, journal editors, senior administrators, and research students opportunities to share experiences and to discuss and promote integrity in research. Read more:
TDR Clinical Research and Development Fellowships
Call for applications
Deadline for submission: 7 March 2019, 16:00 (GMT)
TDR provides fellowships for early- to mid-career researchers and clinical trial staff (e.g. clinicians, pharmacists, medical statisticians, data managers, other health researchers) in low- and middle-income countries (LMICs) to learn how to conduct clinical trials. Read more:
Meta-Analysis Workshops in New York, USA, and London, UK, in April and May 2019
Don't miss this exceptional opportunity to learn how to perform and report a Meta-analysis correctly. Two Meta-analysis workshops are organized in April and May 2019 by Dr. Michael Borenstein in New York, USA (April 08-10, 2019) and London, UK (May 27-29).
About the Instructor
Dr. Michael Borenstein, one of the authors of Introduction to Meta-Analysis, is widely recognized for his ability to make statistical concepts accessible to researchers as well as to statisticians. He has lectured widely on meta-analysis, including at the NIH, CDC, and FDA. Read more: